Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Allergy and Asthma Proceedings
|
September 3, 2021
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis
Gayatri B Patel, Elizabeth A Kudlaty, Amina Guo, et al.
Immunity, Inflammation and Disease
|
May 6, 2017
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps
Julie A Poposki, Aiko I Klingler, Bruce K Tan, et al.
The Journal of Allergy and Clinical Immunology
|
January 9, 2023
Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps
Bao-Feng Wang, Ping-Ping Cao, James E Norton, et al.
The Journal of Allergy and Clinical Immunology
|
October 28, 2017
IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells
Noriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
The Journal of Allergy and Clinical Immunology
|
October 9, 2025
Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polyps
Aiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
International Forum of Allergy & Rhinology
|
April 1, 2022
Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps
Alexander L Schneider, Samuel D Racette, Anthony K Kang, et al.
The Journal of Allergy and Clinical Immunology
|
November 14, 2025
Validation of a risk predictor score for early polyp recurrence in CRSwNP
Junqin Bai, Lutfiyya N Muhammad, Aditi Agarwal, et al.
The Journal of Allergy and Clinical Immunology
|
April 9, 2026
Heterogeneity and Clinical Relevance of Group 2 Innate Lymphoid Cells Subsets in Nasal Polyps
Masanori Kidoguchi, Naruhito Iwasaki, Julie A Poposki, et al.
The Journal of Allergy and Clinical Immunology
|
May 7, 2020
Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease
Whitney W Stevens, Anna G Staudacher, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2016
Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis
Griet A Van Roey, Christopher C Vanison, Jeffanie Wu, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Allergy and Asthma Proceedings
|
September 3, 2021
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis
Gayatri B Patel, Elizabeth A Kudlaty, Amina Guo, et al.
Immunity, Inflammation and Disease
|
May 6, 2017
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps
Julie A Poposki, Aiko I Klingler, Bruce K Tan, et al.
The Journal of Allergy and Clinical Immunology
|
January 9, 2023
Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps
Bao-Feng Wang, Ping-Ping Cao, James E Norton, et al.
The Journal of Allergy and Clinical Immunology
|
October 28, 2017
IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells
Noriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
The Journal of Allergy and Clinical Immunology
|
October 9, 2025
Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polyps
Aiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
International Forum of Allergy & Rhinology
|
April 1, 2022
Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps
Alexander L Schneider, Samuel D Racette, Anthony K Kang, et al.
The Journal of Allergy and Clinical Immunology
|
November 14, 2025
Validation of a risk predictor score for early polyp recurrence in CRSwNP
Junqin Bai, Lutfiyya N Muhammad, Aditi Agarwal, et al.
The Journal of Allergy and Clinical Immunology
|
April 9, 2026
Heterogeneity and Clinical Relevance of Group 2 Innate Lymphoid Cells Subsets in Nasal Polyps
Masanori Kidoguchi, Naruhito Iwasaki, Julie A Poposki, et al.
The Journal of Allergy and Clinical Immunology
|
May 7, 2020
Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease
Whitney W Stevens, Anna G Staudacher, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2016
Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis
Griet A Van Roey, Christopher C Vanison, Jeffanie Wu, et al.
Page
of 10